Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis
  2. Aggor, Felix E Y; Break, Timothy J; Trevejo-Nuñez, Giraldina; Whibley, Natasha; Coleman, Bianca M; Bailey, Rachel D; Kaplan, Daniel H; Naglik, Julian R; Shan, Wei; Shetty, Amol C; McCracken, Carrie; Durum,Scott; Biswas, Partha S; Bruno, Vincent M; Kolls, Jay K; Lionakis, Michail S; Gaffen, Sarah L
  3. Science immunology. 2020, Jun 05; 5(48): pii: eaba0570.
  1. 2.   Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin
  2. Tewary, P.; Yang, D.; de la Rosa, G.; Li, Y. N.; Finn, M. W.; Krensky, A. M.; Clayberger, C.; Oppenheim, J. J.
  3. Blood. 2010, Nov 4; 116(18): 3465-3474.
  1. 3.   Pathogenesis of Hyper IgE Syndrome
  2. Heimall, J.; Freeman, A.; Holland, S. M.
  3. Clinical Reviews in Allergy & Immunology. 2010, Feb; 38(1): 32-38.
  1. 4.   Attenuation of Toll-Like Receptor Expression and Function in Latent Tuberculosis by Coexistent Filarial Infection with Restoration Following Antifilarial Chemotherapy
  2. Babu, S.; Bhat, S. Q.; Kumar, N. P.; Anuradha, R.; Kumaran, P.; Gopi, P. G.; Kolappan, C.; Kumaraswami, V.; Nutman, T. B.
  3. Plos Neglected Tropical Diseases. 2009 3(7): 1, e489-7, e489.
  1. 5.   Clinical Manifestations, Etiology, and Pathogenesis of the Hyper-IgE Syndromes
  2. Freeman, A. F.; Holland, S. M.
  3. Pediatric Research. 2009 65(5): 32R-37R.
  1. 6.   Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
  2. Gerosa, F.; Baldani-Guerra, B.; Lyakh, L. A.; Batoni, G.; Esin, S.; Winkler-Pickett, R. T.; Consolaro, M. R.; De Marchi, M.; Giachino, D.; Robbiano, A.; Astegiano, M.; Sambataro, A.; Kastelein, R. A.; Carra, G.; Trinchieri, G.
  3. Journal of Experimental Medicine. 2008 205(6): 1447-1461.
  1. 7.   The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability
  2. Rajabi, M.; de Leeuw, E.; Pazgier, M.; Li, J.; Lubkowski, J.; Lu, W.
  3. Journal of Biological Chemistry. 2008 283(31): 21509-21518.
  1. 8.   Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3
  2. Taylor, K.; Clarke, D. J.; McCullough, B.; Chin, W.; Seo, E.; Yang, D.; Oppenheim, J.; Uhrin, D.; Govan, J.; Campopiano, D. J.; MacMillan, D.; Barran, P.; Dorin, J. R.
  3. Journal of Biological Chemistry. 2008 283(11): 6631-6639.
  1. 9.   Toward understanding the cationicity of defensins - Arg and Lys versus their noncoded analogs
  2. Zou, G. Z.; de Leeuw, E.; Li, C.; Pazgier, M.; Li, C. Q.; Zeng, P. Y.; Lu, W. Y.; Lubkowski, J.; Lu, W. Y.
  3. Journal of Biological Chemistry. 2007, Jul; 282(27): 19653-19665.
  1. 10.   Crystal structures of human alpha-defensins HNP4, HD5, and HD6
  2. Szyk, A.; Wu, Z. B.; Tucker, K.; Yang, D.; Lu, W. Y.; Lubkowski, J.
  3. Protein Science. 2006, Dec; 15(12): 2749-2760.
  1. 11.   Expression and purification of recombinant human alpha-defensins in Escherichia coli
  2. Pazgier, M.; Lubkowski, J.
  3. Protein Expression and Purification. 2006, Sep; 49(1): 1-8.
  1. 12.   Novel lymphotoxin alpha (LT alpha) knockout mice with unperturbed tumor necrosis factor expression: Reassessing LT alpha biological functions
  2. Liepinsh, D. J.; Grivennikov, S. I.; Klarmann, K. D.; Lagarkova, M. A.; Drutskaya, M. S.; Lockett, S. J.; Tessarollo, L.; McAuliffe, M.; Keller, J. R.; Kuprash, D. V.; Nedospasov, S. A.
  3. Molecular and Cellular Biology. 2006, Jun; 26(11): 4214-4225.
  1. 13.   Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
  2. Ott, M. G.; Schmidt, M.; Schwarzwaelder, K.; Stein, S.; Siler, U.; Koehl, U.; Glimm, H.; Kuhlcke, K.; Schilz, A.; Kunkel, H.; Naundorf, S.; Brinkmann, A.; Deichmann, A.; Fischer, M.; Ball, C.; Pilz, I.; Dunbar, C.; Du, Y.; Jenkins, N. A.; Copeland, N. G.; Luthi, U.; Hassan, M.; Thrasher, A. J.; Hoelzer, D.; von Kalle, C.; Seger, R.; Grez, M.
  3. Nature Medicine. 2006, Apr; 12(4): 401-409.
  1. 14.   Molecular architecture and ligand recognition determinants for T4 RNA ligase
  2. El Omari, K.; Ren, J.; Bird, L. E.; Bona, M. K.; Klarmann, G.; Legrice, S. F. J.; Stammers, D. K.
  3. Journal of Biological Chemistry. 2006, JAN 20; 281(3): 1573-1579.
  1. 15.   Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection
  2. Sun, L. L.; Finnegan, C. M.; Kish-Catalone, T.; Blumenthal, R.; Garzino-Demo, P.; Maggiore, G. M. L.; Berrone, S.; Kleinman, C.; Wu, Z. B.; Abdelwahab, S.; Lu, W. Y.; Garzino-Demo, A.
  3. Journal of Virology. 2005, NOV; 79(22): 14318-14329.
  1. 16.   The role of IL-6 and STAT3 in inflammation and cancer
  2. Hodge, D. R.; Hurt, E. M.; Farrar, W. L.
  3. European Journal of Cancer. 2005, NOV; 41(16): 2502-2512.
  1. 17.   Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: Protective and deleterious effects
  2. Grivennikov, S. I.; Tumanov, A. V.; Liepinsh, D. J.; Kruglov, A. A.; Marakusha, B. I.; Shakhov, A. N.; Murakami, T.; Drutskaya, L. N.; Forster, I.; Clausen, B. E.; Tessarollo, L.; Ryffel, B.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunity. 2005, JAN; 22(1): 93-104.
  1. 18.   Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
  2. Vazquez, N.; Greenwell-Wild, T.; Marinos, N. J.; Swaim, W. D.; Nares, S.; Ott, D. E.; Schubert, U.; Henklein, P.; Orenstein, J. M.; Sporn, M. B.; Wahl, S. M.
  3. Journal of Virology. 2005 79(7): 4479-4491.
  1. 19.   A proinflarnmatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1
  2. Zhang, N.; Inan, S.; Cowan, A.; Sun, R. H.; Wang, J. M.; Rogers, T. J.; Caterina, M.; Oppenheim, J. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005 102(12): 4536-4541.
  1. 20.   Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation
  2. Yang, D.; Chen, Q.; Rosenberg, H. F.; Rybak, S. M.; Newton, D. L.; Wang, Z. Y.; Fu, Q.; Tchernev, V. T.; Wang, M. J.; Schweitzer, B.; Kingsmore, S. F.; Patel, D. D.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Journal of Immunology. 2004, NOV 15; 173(10): 6134-6142.
  1. 21.   Antimicrobial proteins act as "Alarmins" in joint immune defense
  2. Yang, D.; Oppenheim, J. J.
  3. Arthritis and Rheumatism. 2004, NOV; 50(11): 3401-3403.
  1. 22.   A distal region in the interferon-gamma gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2
  2. Bream, J. H.; Hodge, D. L.; Gonsky, R.; Spolski, R.; Leonard, W. J.; Krebs, S.; Targan, S.; Morinobu, A.; O'Shea, J. J.; Young, H. A.
  3. Journal of Biological Chemistry. 2004, SEP 24; 279(39): 41249-41257.
  1. 23.   Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense
  2. Yang, D.; Biragyn, A.; Hoover, D. M.; Lubkowski, J.; Oppenheim, J. J.
  3. Annual Review of Immunology. 2004 22: 181-215.
  1. 24.   Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3
  2. Wu, Z. B.; Hoover, D. M.; Yang, D.; Boulegue, C.; Santamaria, F.; Oppenheim, J. J.; Lubkowski, J.; Lu, W. Y.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(15): 8880-8885.
  1. 25.   Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis
  2. Lyons, M. J.; Yoshimura, T.; McMurray, D. N.
  3. Infection and Immunity. 2002 70(10): 5471-5478.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel